Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
19 Cards in this Set
- Front
- Back
- 3rd side (hint)
amphotericin MOA |
amphoTEARicin. binds ergosterol, forms memb pores, allows leakage of electrolytes and disrupts homeostasis
|
|
|
amphotericin clinical use
|
wide spectrum of SYSTEMIC mycosis: cryptococcus, blastomyces, coccidioides, aspergillus, histoplasma, candida, mucor. Intrathecally for fungal MENINGITIS does not X-BBB |
|
|
amphotericin toxicity
|
shake and bake: fever/ chills, AMPHOTERRIBLE: hypotension, nephrotox, arrythmias, anemia, IV phebitis. HYDRATION REDUCES NEPHROTOXICITY |
|
|
nystatin MOA
|
binds ergosterol, disrupts fungal memb. TOO TOXIC FOR SYSTEMIC USE
|
|
|
nystatin clinical use
|
SWISH AND SWALLOW for oral candidiasis (thrush); topical for diaper rash or vaginal candidiasis
|
|
|
azoles MOA
|
inhibits fungal steroid (ergosterol) syn
|
|
|
azoles clinical use
|
SYSTEMIC mycoses. Fluconazole for cryptococcal meningitis in AIDS pts. Candidal infections of all types. ITRACONAZOLE for blastomyces, coccidioides, histoplasma, , hypercortisolism. CLOTRIMAZOLE and MICONAZOLE for topical fungal infections. |
None
|
|
azole toxicity |
Testosterone hormone syn inhibition (gynecomastia, esp with/ KETOCONAZOLE), liver dysfunction (inhibits P450). |
|
|
flucytosine MOA
|
inhibits DNA syn by conversio nto flurouracil, competes w. uracil
|
|
|
flucytosine clinical use
|
SYSTEMIC FUNGAL INFECTIONS IN COMBO W/ AMPHOTERICIN B. |
|
|
flucytosine toxicity
|
N/V, diarrhea, BM supression |
|
|
ECHINOCANDINS: caspofungin, micafungin, andulafungin: MOA |
inhibits cell wall syn (by inhibiting enzyme that makes beta-glucan) |
None
|
|
caspofungin clinical use |
INVASIVE ASPERGILLOSIS!! CANDIDA |
|
|
caspofungin toxicity
|
GI, flushing by histamine release. |
|
|
terbinafine MOA
|
inhibits fungal enz squalene epoxidase
|
|
|
terbinafine clinical use
|
tx dermatophytoses (esp onchomycosis) SIDE EFFECTS: GI upset, headaches, taste disturbances. |
|
|
griseofulvin MOA
|
interferes w. microtubile fxn. Disrupts mitosis. Deposits in keratin containing tissue (nails)
|
|
|
griseofulvin clinical use
|
oral tx of superficial infection. Inhibits growth of dermatophytes (tinea, ringworm)
|
|
|
griseofulvin tox
|
teratogenic, carcinogenic, confusion, HA, increased P450 (warfarin)
|
|